Old Web
English
Sign In
Acemap
>
Paper
>
Deep Molecular Response to Nilotinib as First-Line Treatment of Bcr-Abl+ Chronic Myeloid Leukemia
Deep Molecular Response to Nilotinib as First-Line Treatment of Bcr-Abl+ Chronic Myeloid Leukemia
2015
Fausto Castagnetti
Gabriele Gugliotta
Massimo Breccia
Giuseppe Rossi
Fabio Stagno
Diamante Turri
Patrizia Pregno
Mario Tiribelli
Elena Trabacchi
Bruno Martino
Angelo Michele Carella
Alessandro Isidori
Ivana Pierri
Marzia Salvucci
Giorgina Specchia
Luciano Levato
Paolo Avanzini
Silvana Capalbo
Anna Merli
Elena Maino
Gianni Binotto
Maria Teresa Bochicchio
Simona Soverini
Michele Cavo
Giuliana Alimena
Giovanni Martinelli
Giuseppe Saglio
Fabrizio Pane
Michele Baccarani
Gianantonio Rosti
Keywords:
Molecular Response
Nilotinib
Myeloid leukemia
ABL
Cancer research
breakpoint cluster region
Medicine
first line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]